arrow_back Back to App

FDA Mission Change: Stronger Protection Against Opioid Addiction

This new act requires the Food and Drug Administration (FDA) to consider the danger of addiction and overdose death from opioids when approving, manufacturing, marketing, and distributing these medications. This aims to enhance public safety and curb the opioid crisis, affecting the availability and prescription practices of powerful pain medications.
Key points
The FDA must now consider the risk of opioid addiction and overdose when approving them.
New rules will impact the manufacturing, marketing, and distribution of opioid medications, enhancing patient safety.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1436
Sponsor: Sen. Manchin, Joe, III [D-WV]
Process start date: 2021-04-28